Skip to main content

Table 2 Side effects

From: Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

 

Gefitinib

Erlotinib

 

Grade 1-2

Grade 3-4

Grade 1-2

Grade 3-4

 

No

%

No

%

No

%

No

%

Skin rash

40

35

6

5

24

53

2

4

Diarrhea

35

30

8

7

15

33

2

4

Nausea/Vomiting

8

7

  

7

16

1

2

Fatigue

5

4

2

2

3

7

2

4

Anorexia

4

3

1

1

    

Instertitial Lung Disease

3

3

      
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us